SCHEMBL7148477

SCHEMBL7148477

CC1CCCN1CCc1cc2cc(-c3cccc(Cl)c3)ccc2o1

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 20/20 0.75
KCNH2 Q12809 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2787432 1.00 HRH3 (0.75) HRH3KCNH2
SCHEMBL2786081 0.92 HRH3 (0.72) HRH3KCNH2
SCHEMBL7146019 0.92 HRH3 (0.72) HRH3KCNH2
SCHEMBL2786825 0.90 HRH3 (0.77) HRH3KCNH2
SCHEMBL2786116 0.88 HRH3 (0.76) HRH3KCNH2
SCHEMBL2787430 0.88 HRH3 (0.75) HRH3KCNH2
SCHEMBL7143762 0.88 HRH3 (0.75) HRH3KCNH2
SCHEMBL2785029 0.87 HRH3 (0.72) HRH3KCNH2
SCHEMBL7143297 0.87 HRH3 (0.72) HRH3KCNH2
SCHEMBL2785004 0.86 HRH3 (1.00) HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370546-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2003-12-17 EP claimed
WO-2002074758-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2002-09-26 WO claimed
EP-1370546-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2003-12-17 EP disclosed
WO-2002074758-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2002-09-26 WO disclosed